The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Notice for tezacaftor, ivacaftor (Vertex Pharmaceuticals Australia Pty Ltd)
Active ingredients
tezacaftor, ivacaftor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Film-coated tablet
Indication
For the treatment of patients with cystic fibrosis
Therapeutic area
Respiratory